⌘K

Login Start Free

PARALLAX HEALTH SCIENCES, INC.·5

Jan 15, 6:30 PM ET

BUCCI CALLI 5

5 · PARALLAX HEALTH SCIENCES, INC. · Filed Jan 15, 2019

Insider Transaction Report

Form 5

Period: 2018-12-31

PARALLAX HEALTH SCIENCES, INC.PRLX

DirectorCFO

Transactions

Award
STOCK OPTIONS
2018-10-10$0.25/sh+1,000,000$250,000→ 2,500,000 total
Exercise: $0.25From: 2018-12-31Exp: 2022-12-31→ COMMON STOCK (1,000,000 underlying)
Exercise/Conversion
STOCK OPTIONS
2018-08-13$0.05/sh−1,071,430$53,572→ 1,428,570 total
Exercise: $0.05From: 2018-08-13Exp: 2018-08-13→ COMMON STOCK (1,071,430 underlying)
Award
WARRANTS
2018-09-30$0.25/sh+15,000$3,750→ 1,045,000 total
Exercise: $0.25From: 2018-09-30Exp: 2021-09-30→ COMMON STOCK (625,000 underlying)
Exercise/Conversion
COMMON STOCK
2018-08-13$0.05/sh+1,071,430$53,572→ 7,452,992 total
Award
PREFERRED STOCK (SERIES C)
2018-09-30$5.00/sh+30,000$150,000→ 1,030,000 total
Exercise: $0.12From: 2018-09-30Exp: 2020-09-30→ COMMON STOCK (1,250,000 underlying)
Tax Payment
STOCK OPTIONS
2018-08-13$0.05/sh−428,570$21,429→ 1,000,000 total
Exercise: $0.05From: 2018-08-13Exp: 2018-08-13→ COMMON STOCK (428,570 underlying)

Footnotes (2)

[F1]Shares issued in exchange for $150,000 in outstanding debt owed by PRLX
[F2]Warrants granted in connection with Series C Preferred Shares at 50%

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT